The Health Resources and Services Administration (HRSA) has announced Chantelle Britton as Director of the Office of Pharmacy Affairs (OPA) within the Office of Special Health Initiatives (OSHI). Britton will provide strategic leadership and oversight for the 340B Program and will guide OPA’s overall policy and implementation work. Britton has served as Acting Director of OPA since December 2023. She brings deep knowledge and experience with the 340B Program, drug pricing issues, health policy, access to care issues, safety-net programs, and HRSA’s federal and external partners to the permanent role. Prior to her appointment as Acting Director, Britton served for eight years as Senior Advisor in the Office of the Director of OPA.
